Global Therapeutics, Inc.
Country not established
- Devices
- 1
What Global Therapeutics, Inc. makes
Global Therapeutics, Inc. manufactures percutaneous transluminal coronary angioplasty (PTCA) catheters, including the MAGELLAN-C series (models C22020, C22520, C23020, and C23520). These devices are designed for coronary artery dilation to treat obstructive coronary artery disease.
The company’s PTCA catheters fall under FDA Class II regulation and are listed under a Premarket Approval (PMA) application. The manufacturer operates from the United States.
Catalogue
- Regimes: PMA, withdrawn Registry: PMA
Frequently asked questions
How many devices does Global Therapeutics, Inc. have in the registry?
The registry currently lists 1 device for Global Therapeutics, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Global Therapeutics, Inc.'s devices?
Among its 1 most recently registered device, Global Therapeutics, Inc. has devices listed in FDA PMA (1 device).
What risk classes do Global Therapeutics, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Global Therapeutics, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Global Therapeutics, Inc. in the registry?
The most recently registered devices listed for Global Therapeutics, Inc. include MAGELLAN-C PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY(PTCA) CATHETERS MODEL C22020, C22520, C23020, & C23520.